
Chiesi has received the first approval for an advanced therapy medicinal product containing stem cells for use in Europe. The …
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand

